Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

The Angels Initiative

Stroke prevention

  Diagnostic Imaging

  Free Subscription

Articles published in Anticancer Res

Retrieve available abstracts of 63 articles:
HTML format

Single Articles

    June 2022
  1. PEPE P, Pepe L, Cosentino S, Ippolito M, et al
    Detection Rate of (68)Ga-PSMA PET/CT vs. mpMRI Targeted Biopsy for Clinically Significant Prostate Cancer.
    Anticancer Res. 2022;42:3011-3015.
    PubMed     Abstract available

    May 2022
  2. WANG MH, Roa W, Wachowicz K, Yahya A, et al
    Early Metabolic Changes in 1H-MRSI Predictive for Survival in Patients With Newly Diagnosed High-grade Glioma.
    Anticancer Res. 2022;42:2665-2673.
    PubMed     Abstract available

  3. TUOHINEN SS, Aula H, Skytta T, Huhtala H, et al
    A Higher Mean Heart Radiation Dose Induces Higher Frequency of Multiple Cardiac Changes.
    Anticancer Res. 2022;42:2519-2529.
    PubMed     Abstract available

    April 2022
  4. PARK HL, Yang B, Shin JE, Kim JY, et al
    Additional Excision Biopsy in Patients With Atypical Ductal Hyperplasia at Ultrasound-guided Vacuum-assisted Breast Biopsy.
    Anticancer Res. 2022;42:2159-2165.
    PubMed     Abstract available

  5. NEUBERGER M, Skladny J, Goly N, Wessels F, et al
    Baseline Modified Glasgow Prognostic Score (mGPS) Predicts Radiologic Response and Overall Survival in Metastatic Hormone-sensitive Prostate Cancer Treated With Docetaxel Chemotherapy.
    Anticancer Res. 2022;42:1911-1918.
    PubMed     Abstract available

  6. PALMISCIANO P, Zaidi SE, Shlobin NA, Sagoo NS, et al
    Intradural Cauda Equina Metastases: A Systematic Review of Clinico-radiological Features, Management, and Treatment Outcomes.
    Anticancer Res. 2022;42:1661-1669.
    PubMed     Abstract available

  7. EICHLER C, Westerhoff A, Warm M, Hanstein B, et al
    Improving Breast Conserving Surgery Using the Faxitron((R)) OR Specimen Radiography System - A Complication Analysis, Cost Evaluation and Literature Review.
    Anticancer Res. 2022;42:1925-1932.
    PubMed     Abstract available

    March 2022
  8. PEPE P, Pennisi M
    Should 68Ga-PSMA PET/CT Replace CT and Bone Scan in Clinical Staging of High-risk Prostate Cancer?
    Anticancer Res. 2022;42:1495-1498.
    PubMed     Abstract available

  9. MATSUDA R, Kotsugi M, Nakase K, Morimoto T, et al
    Awake Craniotomy for Subcortical Brain Metastasis Beneath the Speech Center: A Technical Case Report.
    Anticancer Res. 2022;42:1641-1644.
    PubMed     Abstract available

  10. ARAKI Y, Yamamoto N, Maeda T, Kimura H, et al
    Management of Soft-tissue Tumors With a Size of 2-5 cm, Including Malignancy.
    Anticancer Res. 2022;42:1555-1562.
    PubMed     Abstract available

  11. TASHIRO Y, Aoki T, Hirai T, Koizumi T, et al
    Indocyanine Green Labeling of Tumors in the Liver Recurring After Radiofrequency Ablation Enables Complete Resection by Fluorescence-guided Surgery.
    Anticancer Res. 2022;42:1345-1350.
    PubMed     Abstract available

  12. OKAMOTO A, Funakoshi Y, Oe M, Takai R, et al
    Identification of Breast Cancer Stem Cells Using a Newly Developed Long-acting Fluorescence Probe, C5S-A, Targeting ALDH1A1.
    Anticancer Res. 2022;42:1199-1205.
    PubMed     Abstract available

    February 2022
  13. MITSUI T, Matsuda R, Goda K, Itami H, et al
    A Rare Case of Brain Metastasis of Thymic Carcinoma.
    Anticancer Res. 2022;42:1169-1174.
    PubMed     Abstract available

  14. MATSUDA R, Sato F, Kotsugi M, Morimoto T, et al
    Awake Surgery for Local Recurrence of Brain Metastasis in the Precentral Gyrus After Fractionated Stereotactic Radiotherapy: A Technical Case Report.
    Anticancer Res. 2022;42:1151-1155.
    PubMed     Abstract available

  15. GADDUCCI A, Simonetti E, Mezzapesa F, Cosio S, et al
    Computed Tomography-assessed Skeletal Muscle Index and Skeletal Muscle Radiation Attenuation in Patients With Ovarian Cancer Treated With Primary Surgery Followed by Platinum-based Chemotherapy: A Single-center Italian Study.
    Anticancer Res. 2022;42:947-954.
    PubMed     Abstract available

  16. FUJITA N, Handa A, Park JM
    Peritumoral Hyperintensity at Hepatobiliary Phase Gadoxetic Acid-enhanced MRI in Hepatic Neuroendocrine Tumors.
    Anticancer Res. 2022;42:911-917.
    PubMed     Abstract available

  17. SUGISAWA N, Miyake K, Higuchi T, Oshiro H, et al
    High Incidence of Lymph-node Metastasis in a Pancreatic-cancer Patient-derived Orthotopic Xenograft (PDOX) NOG-Mouse Model.
    Anticancer Res. 2022;42:739-743.
    PubMed     Abstract available

    January 2022
  18. KOIZUMI T, Aoki T, Yamochi T, Tashiro Y, et al
    Determinative Structural Features Identified With Probe-based Confocal Endomicroscopy for the Accurate Diagnosis of Gallbladder Malignancy.
    Anticancer Res. 2022;42:67-73.
    PubMed     Abstract available

  19. HAMA Y, Tate E
    Multiparametric MRI-guided Hypofractionated Intensity-modulated Radiation Therapy With Simultaneous Integrated Boost for Glioblastoma.
    Anticancer Res. 2022;42:329-334.
    PubMed     Abstract available

  20. KONISHI M, Fujita M, Shimabukuro K, Wongratwanich P, et al
    Predictive Factors of Late Cervical Lymph Node Metastasis Using Intraoral Sonography in Patients With Tongue Cancer.
    Anticancer Res. 2022;42:287-292.
    PubMed     Abstract available

    November 2021
  21. TOKISAWA H, Aruga T, Honda Y, Ishiba T, et al
    Safety and Effectiveness of Areola-sparing Mastectomy for Breast Cancer With Intraductal Lesions.
    Anticancer Res. 2021;41:5723-5728.
    PubMed     Abstract available

    October 2021
  22. JANSSEN S, Overhoff D, Froelich MF, Schoenberg SO, et al
    Detectability of Lung Nodules in Ultra-low Dose CT.
    Anticancer Res. 2021;41:5053-5058.
    PubMed     Abstract available

  23. SUN J, Pan S, Yu H, Hu H, et al
    Anti-inflammatory and Anti-thrombotic Efficacy of Targeted Ultrasound Microbubbles on LPS-induced HUVEC Cells.
    Anticancer Res. 2021;41:4761-4769.
    PubMed     Abstract available

    September 2021
  24. MIRKA H, Ferda J, Krakorova G, Vodicka J, et al
    The Use of CT Pattern in Differentiating Non-invasive, Minimally Invasive and Invasive Variants of Lung Adenocarcinoma.
    Anticancer Res. 2021;41:4479-4482.
    PubMed     Abstract available

  25. RIFFEL J, Kannengiesser S, Schoenberg SO, Kaiser AK, et al
    T2-weighted Imaging of the Breast at 1.5T Using Simultaneous Multi-slice Acceleration.
    Anticancer Res. 2021;41:4423-4429.
    PubMed     Abstract available

  26. JACEWICZ M, Rud E, Galtung KF, Noor D, et al
    Cancer Detection Rates in Targeted Transperineal MRI-TRUS Elastic Fusion-guided Prostate Biopsies Performed Under Local Anesthesia.
    Anticancer Res. 2021;41:4395-4400.
    PubMed     Abstract available

  27. MEYER HJ, Hohn AK, Prasse G, Hoffmann KT, et al
    Associations Between ADC Texture Analysis and Tumor Infiltrating Lymphocytes in Brain Metastasis - A Preliminary Study.
    Anticancer Res. 2021;41:4549-4554.
    PubMed     Abstract available

  28. TSUNEMATSU M, Onda S, Yanagaki M, Okui N, et al
    How to Perform Curative Laparoscopic Hepatectomy for Intraoperatively Unidentified Hepatocellular Carcinoma.
    Anticancer Res. 2021;41:4411-4416.
    PubMed     Abstract available

  29. DE SOUZA DV, Suarez Alpire ME, Malacarne IT, DE Castro GM, et al
    Does Panoramic X-ray Induce Cytogenetic Damage to Oral Cells? A Systematic Review With Meta-analysis.
    Anticancer Res. 2021;41:4203-4210.
    PubMed     Abstract available

    August 2021
  30. JANG BS, Song C, Kang SB, Kim JS, et al
    Radiogenomic and Deep Learning Network Approaches to Predict KRAS Mutation from Radiotherapy Plan CT.
    Anticancer Res. 2021;41:3969-3976.
    PubMed     Abstract available

  31. MATSUMOTO T, Toya R, Shimohigashi Y, Watakabe T, et al
    Plan Quality Comparisons Between 3D-CRT, IMRT, and VMAT Based on 4D-CT for Gastric MALT Lymphoma.
    Anticancer Res. 2021;41:3941-3947.
    PubMed     Abstract available

  32. OURA K, Aoki T, Tashiro Y, Matsuda K, et al
    Indocyanine Green Fluorescence Image-guided Laparoscopic Hepatectomy Enabled Resection of a Tumor Invisible With Ultrasonography.
    Anticancer Res. 2021;41:3867-3869.
    PubMed     Abstract available

  33. FRIEDRICH RE, Chin SJ, Luebke AM, Speth US, et al
    A Connective Tissue Neoplasm of the Mandibular Angle Mimicking Stafne's Bone Cavity on Panoramic View.
    Anticancer Res. 2021;41:3983-3988.
    PubMed     Abstract available

    June 2021
  34. SHIRAISHI T, Ogawa H, Kumasaka S, Shimoda Y, et al
    Comparison of Risk Factors for Locally Advanced Lower Rectal Cancer Recurrence Evaluated by Magnetic Resonance Imaging and Pathological Factors Analysed by Longitudinal Slicing Method.
    Anticancer Res. 2021;41:3169-3178.
    PubMed     Abstract available

  35. KEENAN BP, VAN Loon K, Khilnani AD, Fidelman N, et al
    Molecular and Radiological Features of Microsatellite Stable Colorectal Cancer Cases With Dramatic Responses to Immunotherapy.
    Anticancer Res. 2021;41:2985-2992.
    PubMed     Abstract available

  36. WATANABE K, Hayashi T, Katsumata M, Sano K, et al
    Development of Uterine Leiomyosarcoma During Follow-up After Caesarean Section in a Woman With Uterine Leiomyoma.
    Anticancer Res. 2021;41:3001-3010.
    PubMed     Abstract available

  37. DRIKOS I, Boutou E, Kastritis PL, Vorgias CE, et al
    BRCA1-BRCT Mutations Alter the Subcellular Localization of BRCA1 In Vitro.
    Anticancer Res. 2021;41:2953-2962.
    PubMed     Abstract available

    May 2021
  38. ELLIOT AH, Othman BN, Suzuki C, Blomqvist L, et al
    Pretreatment MRI in Primary Rectal Cancer as a Predictor for Oncological Outcomes After Surgery for Local Recurrence.
    Anticancer Res. 2021;41:2459-2465.
    PubMed     Abstract available

  39. ZISSER L, Kulterer OC, Itariu B, Fueger B, et al
    Diagnostic Role of PET/CT Tracers in the Detection and Localization of Tumours Responsible for Ectopic Cushing's Syndrome.
    Anticancer Res. 2021;41:2477-2484.
    PubMed     Abstract available

  40. SHIROSHITA A, Kurosaki M, Takeshita M, Kataoka Y, et al
    Medical Thoracoscopy, Computed Tomography-guided Biopsy, and Ultrasound-guided Biopsy for Malignant Pleural Mesothelioma: A Systematic Review.
    Anticancer Res. 2021;41:2217-2225.
    PubMed     Abstract available

  41. NISHIO J, Nakayama S, Nabeshima K, Yamamoto T, et al
    Current Update on the Diagnosis, Management and Pathogenesis of Elastofibroma Dorsi.
    Anticancer Res. 2021;41:2211-2215.
    PubMed     Abstract available

    April 2021
  42. SEKITO S, Terabe T, Shibahara T, Onishi T, et al
    Usefulness of Biparametric Magnetic Resonance Imaging Combined With Prostate Specific Antigen Density in Pre-biopsy Detection of Clinically Insignificant Prostate Cancer.
    Anticancer Res. 2021;41:2183-2186.
    PubMed     Abstract available

  43. GADDUCCI A, Simonetti E, Guidoccio F, Manca G, et al
    Have Volume-based Parameters of Positron Emission Tomography/Computed Tomography Prognostic Relevance for Patients With Potentially Platinum-responsive Recurrent Ovarian Cancer? A Single Center Italian Study.
    Anticancer Res. 2021;41:1937-1944.
    PubMed     Abstract available

  44. JO S, Sebro R
    CT Attenuation and Cross-sectional-area Index of the Pectoralis Are Associated With Prognosis in Sarcoma Patients.
    Anticancer Res. 2021;41:1927-1935.
    PubMed     Abstract available

    March 2021
  45. PERL RM, Portugall J, Hinterleitner C, Hinterleitner M, et al
    Differences Between CT-Perfusion and Biphasic Contrast-enhanced CT for Detection and Characterization of Hepatocellular Carcinoma: Potential Explanations for Discrepant Cases.
    Anticancer Res. 2021;41:1451-1458.
    PubMed     Abstract available

  46. MEYER HJ, Wienke A, Surov A
    Pre-treatment Apparent Diffusion Coefficient Does Not Predict Therapy Response to Radiochemotherapy in Cervical Cancer: A Systematic Review and Meta-analysis.
    Anticancer Res. 2021;41:1163-1170.
    PubMed     Abstract available

    February 2021
  47. WADA Y, Aoki T, Fujimori A, Ohike N, et al
    Intraoperative Shear Wave Elastography as a Quantitative Predictor of Pancreatic Fibrosis and Exocrine Function.
    Anticancer Res. 2021;41:1013-1019.
    PubMed     Abstract available

  48. MANDATO VD, Torricelli F, Mastrofilippo V, Pirillo D, et al
    Impact of a Province-wide Endometrial Cancer Guideline on Daily Practice.
    Anticancer Res. 2021;41:937-948.
    PubMed     Abstract available

  49. DEBICKA-KUMELA M, Romanowska-Dixon B, Karska-Basta I, Kowal J, et al
    The Evaluation of the Malignant Characteristics of Conjunctival Lesions Based on the Dermatoscopic Algorithm.
    Anticancer Res. 2021;41:895-903.
    PubMed     Abstract available

  50. OSHIRO H, Tome Y, Miyake K, Higuchi T, et al
    A Novel Orthotopic Mouse Model of Lung Metastasis Using Fluorescent Patient-derived Osteosarcoma Cells.
    Anticancer Res. 2021;41:635-640.
    PubMed     Abstract available

    January 2021
  51. GADDUCCI A, Cosio S
    The Prognostic Relevance of Computed Tomography-assessed Skeletal Muscle Index and Skeletal Muscle Radiation Attenuation in Patients With Gynecological Cancer.
    Anticancer Res. 2021;41:9-20.
    PubMed     Abstract available

  52. DI MARTINO G, Lissoni AA, Ferrari D, DI Meo ML, et al
    Dose-dense Neoadjuvant Chemotherapy With Paclitaxel and Carboplatin in Cervical Cancer: Efficacy on Pathological Response.
    Anticancer Res. 2021;41:497-502.
    PubMed     Abstract available

  53. SOHDA M, Miyazaki T, Watanabe T, Nakazawa N, et al
    Utility of Thermography of Reconstructed Gastric Conduit for Predicting Postoperative Anastomotic Leakage After Esophagectomy for Esophageal Cancer.
    Anticancer Res. 2021;41:453-458.
    PubMed     Abstract available

  54. SANDSTROM H, Toma-Dasu I, Chung C, GArding J, et al
    Simultaneous Truth and Performance Level Estimation Method for Evaluation of Target Contouring in Radiosurgery.
    Anticancer Res. 2021;41:279-288.
    PubMed     Abstract available

    December 2020
  55. MACAIONE I, Galvano A, Graceffa G, Lupo S, et al
    Impact of BMI on Preoperative Axillary Ultrasound Assessment in Patients With Early Breast Cancer.
    Anticancer Res. 2020;40:7083-7088.
    PubMed     Abstract available

    November 2020
  56. SHIMODA M, Kim SJ, Tokuda Y, Sota Y, et al
    Effect of Computer-aided Detection System Use on the Duration of MRI-guided Biopsy of the Breast.
    Anticancer Res. 2020;40:6437-6441.
    PubMed     Abstract available

  57. BUWENGE M, Alitto AR, Cilla S, Capocaccia I, et al
    Simultaneous Integrated Radiotherapy Boost to the Dominant Intraprostatic Lesion: Final Results of a Phase I/II Trial.
    Anticancer Res. 2020;40:6499-6503.
    PubMed     Abstract available

    October 2020
  58. SIDDIQUE DA, Rahal MA, Trevino K, Wu HH, et al
    Endoscopic Ultrasound-guided Sampling of Solid Pancreatic Lesions: A Comparative Analysis of 25 Gauge Versus 22 Gauge Core Biopsy Needles.
    Anticancer Res. 2020;40:5845-5851.
    PubMed     Abstract available

  59. YAMAMURA K, Beppu T, Sato N, Kinoshita K, et al
    Complete Removal of Adrenal Metastasis in Hepatocellular Carcinoma Using Indocyanine Green Fluorescent Imaging.
    Anticancer Res. 2020;40:5823-5828.
    PubMed     Abstract available

  60. MUHLHOFER H, Gersing A, Pfeiffer D, WOrtler K, et al
    Preoperative Evaluation of Myxofibrosarcoma: Prognostic Value and Reproducibility of Different Features on MRI.
    Anticancer Res. 2020;40:5793-5800.
    PubMed     Abstract available

  61. JOHNSON JD, Rainer WG, Rose PS, Houdek MT, et al
    Utility of Bone Scintigraphy and PET-CT in the Surgical Staging of Skeletal Chondrosarcoma.
    Anticancer Res. 2020;40:5735-5738.
    PubMed     Abstract available

    September 2020
  62. VAN BEECK A, VAN DE Sande M, VAN Praag V, Dammerer D, et al
    Clinical Outcome of Surgically Treated Leiomyosarcoma of the Extremities: A Retrospective Overview.
    Anticancer Res. 2020;40:5319-5325.
    PubMed     Abstract available

  63. KOBAYASHI K, Kaira K, Kagamu H
    Recovery of the Sensitivity to Anti-PD-1 Antibody by Celecoxib in Lung Cancer.
    Anticancer Res. 2020;40:5309-5311.
    PubMed     Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Diagnostic Imaging is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.